assistivetechnologyblog.com
Israel Biotechnology Company Matricelf Cures Paralysis in Mice, Eyes Human Trials in 2024
This 3D bioprinting technology, developed by Tel Aviv University was tested on mice with both acute and chronic paralysis. The results from the tests showed that all mice with acute paralysis regained the ability to walk. The success rate in mice with chronic paralysis was 80%.
Venkat